Prescription drug · NDA
Nipride Rtu (sodium nitroprusside) NDC 51754-1029
Sodium nitroprusside .2 mg/mL · Injection, Solution · Intravenous · EXELA PHARMA SCIENCES, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51754-1029-1 | 51754102901 | 1 VIAL in 1 CARTON (51754-1029-1) / 100 mL in 1 VIALMarketed from Jul 20, 2018 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Nipride Rtu
- Generic name (nonproprietary)
- sodium nitroprusside
- Active ingredients
- Sodium nitroprusside — .2 mg/mL
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Labeler
- EXELA PHARMA SCIENCES, LLC
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 209387
- Marketing start
- Listing expires
- Other FDA classes
- Vasodilation (Physiologic effect)
- Identifiers
- Product ID 51754-1029_ed0040fb-c481-4477-8712-00fa6350cd70SPL ID ed0040fb-c481-4477-8712-00fa6350cd70SPL set ID 5acf0836-93ff-4064-b888-3f560e8a558dRxCUI 1876368, 1876373, 1999185, 1999187, 2052423, 2052424UNII EAO03PE1TC
- Pharmacologic class
- Vasodilator
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N451754102901followed by a unit qualifier and the quantityPackage 51754-1029-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Sodium nitroprusside is a direct acting vasodilator indicated for: • Immediate reduction of blood pressure ( 1.1 ) • Producing controlled hypotension to reduce bleeding during surgery. ( 1.2 ) • Treatment of acute heart failure to reduce left ventricular end-diastolic pressure, pulmonary capillary wedge pressure, peripheral vascular resistance and mean arterial blood pressure. ( 1.3 ) 1.1 Immediate Reduction of Blood Pressure Sodium nitroprusside is indicated for the immediate reduction of blood pressure of adult and pediatric patients in hypertensive crises. 1.2 Induction and Maintenance of Controlled Hypotension Sodium nitroprusside indicated for induction and maintenance of controlled hyp…
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 209387
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Nipride Rtusodium nitroprusside | Sodium nitroprusside .5 mg/mL | Injection, SolutionIntravenous | EXELA PHARMA SCIENCES, LLC | 51754-1006 |